Chemists urge govt to reconsider OTC drug rules
Ahmedabad: Two major chemist groups, the All India Organization of Chemists and Druggists ( AIOCD ) and the Federation of Gujarat State Chemists and Druggists Association ( FGSCDA ), have asked the central govt to consult them before finalising the list of over-the-counter (OTC) medicines that can be sold without a prescription.In a letter to the Union health ministry, the two bodies demanded the withdrawal of a rule introduced during Covid-19 — GSR 220 (E) — which allowed home delivery of medicines. "This law is being misused by online channels and companies. Prescriptions and retail pharmacists are being bypassed, due to which medicines are being sold indiscriminately through online portals," the memorandum states.They warn the move could lead to "inappropriate, unnecessary and uncontrolled use of drugs," the spread of "fake and substandard medicines," and a rise in antibiotic misuse with "long-term threats to public health."The groups, representing over 13 lakh chemists across India, welcomed the govt's decision to refer the issue to the digital technical advisory board (DTAB) but stressed the need to include retail chemists in any discussion, as they are key players in the country's medicine supply chain.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 hours ago
- The Hindu
What is the COVID-19 situation in India?
The story so far: After a rise in COVID-19 numbers in Southeast Asia, India has started to show an uptick in the number of cases over the last couple of weeks. The numbers slowly grew to hit 5,755 cases (as of Saturday 5:30 pm) as per the Ministry of Health's COVID-19 dashboard. What is the medical advice? The same dashboard states that 5,484 people have been discharged. Even as the numbers rise, doctors and experts have repeatedly stated that seasonal spikes and dips in COVID-19 cases are to be expected, since it had moved from a pandemic to an endemic infection. The COVID-19 virus is co-circulating with other seasonal viruses, they point out, and currently the dominant strain is an Omicron sub-variant from which the subcontinent has adequate immunity. The cases have not been severe; from the point of transmissibility too, the R0 (reproductive number) is not that worrying to indicate a high contagion factor. What is the situation in the country today? As of now, the variants of COVID-19 doing the rounds in India are descendants of the Omicron variant, first reported in November 2021. The emerging sub-variants, NB.1.8.1 and LF.7, driving the current COVID-19 surge are descendants of JN.1, a sub-lineage of the Omicron BA.2.86 variant. In Kerala for instance, a senior health department official said that 'almost all of the samples sent for whole genome sequencing from the State have shown that the circulating virus variant is LF.1, one of the descendants of Omicron, the immune evasiveness of which is quite well-known.' Cases have mostly been mild, according to the Indian Council of Medical Research (ICMR). The reported symptoms are those of the common cold or seasonal flu, including fever, cough, sore throat, runny nose, headache, fatigue, body aches, and loss of appetite. P. Senthur Nambi, senior consultant, Infectious Diseases, Apollo Hospitals, Chennai, said most of the COVID-19 patients he had seen so far have done well. 'Most of them had only an upper respiratory infection. These patients were managed based on their symptoms and most of them did not require any COVID specific antiviral medications. Prior exposure to the infection, the effects of the vaccines taken or a combination of both factors with vaccine-induced antibodies could be playing a protective role,' he explained. 'The key difference with these new strains,' said Sujan Bardhan, consultant (Tuberculosis and chest diseases), Narayana Hospital, R.N. Tagore Hospital, Kolkata, 'is their speed, not their severity. Hospitals are well-prepared and the healthcare system remains under no immediate strain. Nonetheless, the importance of basic preventive measures cannot be overstated.' What is the vaccine position? India launched the world's largest COVID-19 immunisation drive in January 2021. To date, over 220 crore doses of COVID-19 vaccines have been administered in the country as per the CoWIN dashboard. These were primarily of the two vaccines available then, AstraZeneca's Covishield and Bharat Biotech's Covaxin. Rajiv Bahl, Director General of ICMR, has said there is absolutely no need to initiate mass booster doses for COVID-19 vaccines at present, and neither is there a direction from the Central government on this. As cases rise, Dr. Bahl noted that individual doctors could recommend booster doses to patients on a case-to-case basis. He further explained that the need for mass vaccination, while not felt at present, could arise, with perhaps a mutation in the virus or its spread. 'For that, India already has the capacity to scale up production and provide for the general public. We have done this before and there is no need to panic,' he said. Since vaccines which were stocked and used in 2021 and 2022 have now fallen into disuse and expired, there are no stocks at present, a government official said. The official, however, added that the government could direct manufacturers to produce more stocks as and when necessary. Most States, including Kerala, Tamil Nadu, Karnataka and West Bengal, have no stocks or supplies of the vaccine at present either in the government or private sector. Are vaccines needed at present? Doctors across the board say that at present they see no need for a mass vaccination drive. 'By the time Omicron ran its course, almost all of our population had been exposed to the virus. Even when this antibody protection wanes, the long-term immune memory remains. This innate immunity plus the vaccine-derived immunity through good coverage of the initial two doses means that most people have strong hybrid immunity against COVID-19,' the Kerala health department official said. Previous vaccines may not be very effective against the Omicron variants but would, however, offer protection against serious forms of the disease. Though two indigenously developed nasal vaccines specifically targeting the Omicron variant from Bharat Biotech and Indian Immunologicals, as well as another vaccine for the Omicron variant, were made available in the Indian market, the uptake was low, doctors said. Kiran Madala, a Hyderabad-based doctor, part of an international group of genetic epidemiologists under the COVID Treatment Exchange Organisation, said the current World Health Organization guidelines recommend vaccines primarily for individuals above 70 years of age, those who are immunocompromised, and patients with multiple co-morbidities. Children, especially those aged two to six years, do not need vaccination unless they have underlying health issues or are immunosuppressed. Dr. Nambi in Chennai said some patients, those who have travel obligations, have requested the vaccines, but none are available at present. 'But I wish that there was an option of vaccination, not for the general population in large but for two subsets of patient groups in whom the infection could cause problems,' he said. One, those who have not received any COVID-19 vaccines or missed an infection, leaving them without immunity, while the second are those with co-morbidities and who are immuno-compromised. T. Jacob John, retired professor of clinical virology at Christian Medical College, Vellore, also said that the elderly and immunocompromised people needed to be vaccinated again, irrespective of whether they were fully vaccinated (two doses and a booster) or had been exposed to the virus earlier. State governments, however, have taken a more cautious stance: 'Whether vaccination is required or not depends on many factors,' said T. S. Selvavinayagam, T.N. Director of Public Health and Preventive Medicine. 'We need to study the epidemiology of the current cases before commenting on the requirement for vaccination now.' Kerala has said it was 'not advocating for or against COVID booster shots' because of the lack of epidemiological data that booster doses offered enhanced protection against emerging immune-evasive variants. What next? The Delhi High Court, earlier this week, directed the Centre to submit a thorough status report detailing its actions regarding the policy for sample collection, collection centres, and transportation of samples. The court also stressed urgency to finalise and implement Standard Operating Procedures. As the virus continues to adapt, so must we, Dr. Bardhan pointed out. Staying informed and following trusted health sources, personal protection and hygiene measures such as hand washing, avoiding crowded places when possible or masking up, refraining from going outdoors when ill and maintaining a healthy, well-balanced lifestyle could help navigate this phase and any more to come. Compiled by Zubeda Hamid, with inputs from C. Maya in Kerala, Serena Josephine M. in Chennai, Bindu Shajan Perappadan in Delhi, Afshan Yasmeen in Bengaluru, Shrabana Chatterjee in Kolkata and Siddharth Kumar Singh in Hyderabad.
The Hindu
3 hours ago
- The Hindu
Bihar had lowest sex ratio at birth in 2022, in decline for three years: CRS data
Bihar has recorded the lowest sex ratio at birth for 2022 among all States and Union Territories, reporting just 891 girls born for every 1,000 boys, according to the Civil Registration System's vital statistics report, released this week by the Office of the Registrar General of India. Bihar is also the only State that has seen its sex ratio at birth declining consistently since 2020, the year from which this data is available for the State. In 2020, the State reported a sex ratio at birth of 964, which fell to 908 in 2021, before further dipping to 891 in 2022. This comes ahead of the Bihar Assembly election, at a time when political parties have been actively targeting women voters, including with promises of cash transfers in polls in Haryana, Maharashtra, and Jharkhand. In 2024, 47.6% of Bihar's 7.64 crore electors were women, though voter turnout in the State during the 2024 general election showed that 50.4% of votes polled came from women. Other States with low sex ratios at birth in 2022 were Maharashtra (906), Telangana (907), and Gujarat (908). On the other hand, Nagaland had the highest figure of 1,068, followed by Arunachal Pradesh (1,036), Ladakh (1,027), Meghalaya (972), and Kerala (971). Assam, which had reported 863 girl babies born in 2021 for every 1,000 boys, the lowest ratio for that year, showed an improvement to 933 in 2022. Delayed reports A month after the Office of the RGI released the Civil Registration System (CRS), Sample Registration System (SRS), and Medical Certification of Cause of Death (MCCD) reports for 2021, after a four-year-delay, the government this week released the CRS and MCCD data for 2022 as well. However, the SRS report for 2022 has not yet been made public. The SRS is the largest demographic survey in the country, meant to provide annual estimates on fertility and mortality indicators, including birth and death rates. The CRS and MCCD reports provide data on registered births and deaths, and the causes of medically certified registered deaths respectively. Drop in deaths in 2022 The CRS report showed that there were 86.5 lakh registered deaths in 2022, a stark drop from the 102.2 lakh registered deaths in 2021, the year in which the COVID-19 pandemic took its highest toll in the country. The Hindu has previously reported on how the 2021 data, recording 'excess deaths' in comparison to the norm, showed that the initial government reporting of COVID-19 deaths for the year was an underestimate. The CRS 2022 data also showed a hike in registered births, rising to 254.4 lakh registered births, in comparison to 242 lakh the previous year. Birth, death registration trends State-level birth registration statistics in the 2022 report show that, since 2013, States like Uttar Pradesh, Bihar, Madhya Pradesh, Telangana, and Uttarakhand have seen a general trend of registered births rising, despite occasional dips. On the other hand, States and UTs like Tamil Nadu, Kerala, Himachal Pradesh, Punjab, and Delhi saw a general decline in registered births, despite fluctuations. Of the total registered births in 2022, 52.4% were boys while 47.6% were girls. While about 43% of the births were registered in rural areas, 56.5% were registered in urban areas. The report added that the number of registered stillbirths in 2022 fell to 1.15 lakh from 1.24 lakh the previous year. Of the total registered deaths in 2022, the shares of men and women were 60.4% and 39.6% respectively. The report showed that 59.5% of the registered deaths were in rural India while 40.5% were in urban areas.
United News of India
3 hours ago
- United News of India
No need to panic because of rising Covid cases, just be cautious: Dr Wali
New Delhi, June 7 (UNI) The Covid cases are rising rapidly and the deaths have alerted us but there is no need to panic, prominent doctor Mohsin Wali has said. Dr. Wali, who has had the unique privilege of serving three Presidents of India -- R. Venkataraman, Dr. Shankar Dayal Sharma, and Pranab Kumar Mukherjee -- said most of the people infected with the virus will have mild to moderate respiratory illness and will not require special treatment. While the potency of the current strain of the Covid virus has increased slightly, there is no need to panic, he says, adding people should, instead, be cautious about its transmission and follow Covid-appropriate behavior. 'This is a respiratory virus, a sars virus, and the current variant is a sub-variant of Omicron. Its spike protein has changed, and it has increased its ability to bind to cells. However, we need to fear not the virus itself but its transmission," he said. 'Fearing transmission means we need to wear masks, use sanitizers, maintain social distancing, and follow covid-appropriate protocols. We should not go directly to (interact with) small children or elderly people after coming home from outside," he suggested. "If you have cough, cold, and fever for more than three days, get tested for covid. If the test is positive, don't panic. Isolate yourself and follow the doctor's advice," he added. People with asthma, cold, and fever along with heart or kidney disease should be cautious and those who have undergone kidney or liver transplant should also be careful. "We don't need to do anything more than this. The government is monitoring it, and whenever there is another variation, it will be caught," he says. UNI AM AKK BM
